About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,762 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,762 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7201-7220 of 28,762 trials

RecruitingA Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved IndicationThe main purpose of this study is to assess the amount of mirikizumab in breast milk in women who are breastfeeding who are receiving stable maintenance doses of mirikizumab for…NCT07612267·Glenview, Illinois and 19 others Active not recruitingClinical Trial Multi-analyte Blood TestThis is a clinical trial designed to evaluate the performance of a multi-analyte blood test alone to ultrasound alone for the detection of HCC within a population that is at high…NCT03694600·Chandler, Arizona and 37 others

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

CompletedA Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.To determine the effects of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized on atorvastatin therapy…NCT00754507·Los Angeles, California and 12 others

RecruitingA Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 DiabetesThe goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes (T1D) who have been having…NCT05762107·Birmingham, Alabama and 45 others

CompletedBEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.This is a Phase II study in 2 stages, evaluating BEZ235 plus best supportive care (BSC) versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (pNET)…NCT01658436·Indianapolis, Indiana and 16 others

CompletedCerebral Hemorrhage Risk in Hereditary Hemorrhagic TelangiectasiaThis study is one of the three projects of an NIH Rare Disease Clinical Research Consortium.NCT01158807·Phoenix, Arizona and 18 others

RecruitingA Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseThis is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to…NCT07184944·Colorado Springs, Colorado and 89 others

TerminatedStudy of Brexucabtagene Autoleucel in Adults With Rare B-cell MalignanciesMaster protocol: The goal of this master clinical study is to test how well the study drug, brexucabtagene autoleucel, works in participants with rare B-cell malignancies…NCT05537766·Duarte, California and 25 others

RecruitingA Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerThis study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer.NCT05253651·Glendale, Arizona and 365 others

CompletedA Study to Investigate Vamikibart (RO7200220) in Diabetic Macular EdemaStudy BP43445 is a phase II, multicenter, randomized, double-masked, active comparator-controlled study to investigate the efficacy, safety, tolerability, pharmacokinetics, and…NCT05151731·Arcadia, California and 73 others

CompletedA Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic DermatitisA study to compare efficacy of Protopic Ointment to that of Elidel Cream in treating patients with Atopic DermatitisNCT00666302·Birmingham, Alabama and 14 others

CompletedStudy to Assess the Safety, Tolerability and Pharmacokinetics of Oral Brexpiprazole (OPC- 34712) in Adolescents With SchizophreniaThe purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of oral brexpipirazole in adolescent subjects with schizophrenia or Other Related…NCT02411695·Little Rock, Arkansas and 9 others

TerminatedSafety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) PatientsThe purpose of this study is to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of M254 after administration of a single ascending dose and repeat doses in…NCT03866577·Los Angeles, California and 27 others

CompletedInduction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye PollenGrass MATA (modified pollen allergen tyrosine adsorbate) has been developed to provide pre-seasonal specific immunotherapy for patients with hypersensitivity to grass and rye…NCT00104377·Overland Park, Kansas and 10 others

CompletedOTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung NodulesThis is a phase 2, multi-center, single dose, open-label, exploratory study in suspected lung cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/positron…NCT02872701·Boston, Massachusetts and 5 others

CompletedA Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional TherapyThis is a randomized, parallel-arm, multicenter study to compare the safety and efficacy profiles of SEL-212 and KRYSTEXXA®.NCT03905512·Anniston, Alabama and 42 others

CompletedA Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)To determine the relative clinical efficacy of zidovudine ( AZT ) plus didanosine (ddI), AZT plus zalcitabine ( ddC ), AZT alternating monthly with ddI, and AZT/ddI plus…NCT00000781·Birmingham, Alabama and 95 others

CompletedSafety Study of Mesenchymal Precursor Cells in Type 2 DiabetesThis study is being conducted to assess the overall safety and tolerability of a single intravenous infusion of three doses of Mesenchymal Precursor Cells versus Placebo in…NCT01576328·Garden Grove, California and 17 others

CompletedTrial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial FibrillationThis is a prospective, randomized, open-label, blinded end-point evaluation trial.NCT02942407·Huntsville, Alabama and 57 others

CompletedA Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaThe purpose of the study is to evaluate whether treatment with ibrutinib as a monotherapy results in a clinically significant improvement in progression free survival (PFS) as…NCT01578707·La Jolla, California and 75 others

PreviousPage 361 of 1439Next

Heart Diseasein Ohio